Immunolocalization of eicosanoid enzymes and growth factors in human myometrium and fetoplacental tissues in failed labor inductions

OBJECTIVE: To investigate the correlation between myometrial-derived eicosanoids and growth factors during the onset of parturition. METHODS: Myometrial samples were obtained from patients who were delivered by cesarean for failed induction or abnormal fetal heart rate tracings but who experienced normal labor progression until the occurrence of the abnormal tracing. Placentas and fetal membranes were obtained from patients with normal labor, no labor, and failed labor progression. The tissues were processed and sections were immunostained for cyclooxygenases, prostacyclin synthetase (PGI2-S), thromboxane A2 synthetase (TXA2-S), 5-lipoxygenase, epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha), and EGF receptor, using specific antibodies directed against these molecules. RESULTS: Myometrial and fetoplacental tissues from women with normal labor, no labor, and failed labor contain immunoreactive cyclooxygenases, 5-lipoxygenase, TXA2-S, PGI2-S, EGF, TGF-alpha, and EGF receptor. However, their immunostaining intensity, with the exception of EGF receptor, decreased substantially in myometrium from women with failed labor induction compared with those having normal labor progression. No difference was noted in the immunostaining intensity of growth factors and eicosanoid enzymes in the fetoplacental membranes from these patients, except for cyclooxygenases, which were prominent in fetal membranes from normal labor compared with failed labor and no labor. CONCLUSION: Myometrial-derived eicosanoids and growth factors may be important in processes of parturition because reduction in their production in the myometrium is correlated with failed labor induction. Because of the regulatory action of growth factors in eicosanoid biosynthesis in uterine and fetoplacental tissues, EGF/TGF-alpha may indirectly influence the process of parturition by regulating eicosanoid production in the myometrium.

This article has been cited by other articles:

				M. L. Ribeiro, J. Aisemberg, S. Billi, M. G. Farina, R. Meiss, S. McCann, V. Rettori, M. Villalon, and A. M. Franchi Epidermal growth factor prevents prepartum luteolysis in the rat PNAS, May 31, 2005; 102(22): 8048 - 8053. [Abstract] [Full Text] [PDF]

				G. C.S. Smith, W. X. Wu, and P. W. Nathanielsz Lipoxygenase gene expression in baboon intrauterine tissues in late pregnancy and parturition Mol. Hum. Reprod., June 1, 2001; 7(6): 587 - 594. [Abstract] [Full Text] [PDF]

				N. Chegini, C. Ma, J. Davis, P. Duff, and C. Rosa Differential Expression of Transforming Growth Factor-{beta}1 and Transforming Growth Factor-{beta} Receptors in Myometrium of Women With Failed Induction of Labor, No Labor, and Preterm Labor Reproductive Sciences, September 1, 1999; 6(5): 258 - 263. [Abstract] [PDF]

				N.L. Brown, D.M. Slater, S.A. Alvi, M.G. Elder, M.H.F. Sullivan, and P.R. Bennett Expression of 5-lipoxygenase and 5-lipoxygenase-activating protein in human fetal membranes throughout pregnancy and at term Mol. Hum. Reprod., July 1, 1999; 5(7): 668 - 674. [Abstract] [Full Text] [PDF]

				P. Hatthachote and J. I. Gillespie Complex Interactions Between Sex Steroids and Cytokines in the Human Pregnant Myometrium: Evidence for an Autocrine Signaling System at Term Endocrinology, June 1, 1999; 140(6): 2533 - 2540. [Abstract] [Full Text]

				P. Hatthachote, J. Morgan, W. Dunlop, G. N. Europe-Finner, and J. I. Gillespie Gestational Changes in the Levels of Transforming Growth Factor-{beta}1 (TGF{beta}1) and TGF{beta} Receptor Types I and II in the Human Myometrium J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2987 - 2992. [Abstract] [Full Text]